<DOC>
	<DOCNO>NCT00060905</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness Depakote ER compare placebo treatment bipolar disorder , manic mixed type adult .</brief_summary>
	<brief_title>An Inpatient Study Effectiveness Safety Depakote ER Treatment Mania/Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>INCLUSION CRITERIA Current primary diagnosis bipolar I disorder , mania mixed type Acute exacerbation mania associate bipolar disorder define Mania Rating Scale score &gt; = 18 Hospitalized 7 day time Screening process admit History least one prior manic mixed episode within past 3 year , exclusive current episode . Prior manic mixed episode must separate current episode least 2 month sustain improvement EXCLUSION CRITERIA History schizophrenia schizoaffective disorder Axis I ( e.g. , anxiety disorder ) , Axis II ( e.g. , personality disorder ) would interfere compliance confound interpretation study result Current manic mixed episode druginduced secondary medical disorder ( e.g. , AIDS , corticosteroid ) Current manic mixed episode believe caused antidepressant use ( i.e. , antidepressantinduced mania ) Had first manic episode age 60 Has ever take clozapine Has receive depot neuroleptic medication within one interinjection interval first dose study drug Urine toxicology screen positive phencyclidine ( PCP ) , opiates , cocaine amphetamine History active alcohol substance dependence within past 3 month . History fail treatment adequate valproate therapy bipolar disorder Has take Depakote ( DR ER ) regularly last 30 day Has serious violent , homicidal , suicidal ideation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Bipolar Disorder ( manic mixed type )</keyword>
</DOC>